ImageneBio, Inc. Current Liabilities
ImageneBio, Inc. (IMA) had Current Liabilities of $6.57 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $6.57M.
- 2026-03-31: Liabilities, Current $6.63M.
- 2025-12-31: Liabilities, Current $11.23M.
- 2025-09-30: Liabilities, Current $11.14M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.57M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $6.63M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $11.23M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $11.14M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.32M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $8.79M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $17.21M 10-K · filed 2026-03-10 | $10.78M 10-K · filed 2025-03-06 |
| 2024-09-30 | $9.24M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $8.20M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $10.17M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $14.21M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $19.27M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $12.01M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $13.95M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $21.50M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $25.04M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $28.51M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $25.33M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $27.19M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $30.57M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $30.54M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $30.02M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $28.33M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |